Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites.
Möginger U, Resemann A, Martin CE, Parameswarappa S, Govindan S, Wamhoff EC, Broecker F, Suckau D, Pereira CL, Anish C, Seeberger PH, Kolarich D.
Möginger U, et al. Among authors: kolarich d.
Sci Rep. 2016 Feb 4;6:20488. doi: 10.1038/srep20488.
Sci Rep. 2016.
PMID: 26841683
Free PMC article.